Home/Filings/4/A/0001493152-18-005016
4/A//SEC Filing

Gormally John J 4/A

Accession 0001493152-18-005016

CIK 0001321834other

Filed

Apr 9, 8:00 PM ET

Accepted

Apr 10, 8:40 PM ET

Size

5.2 KB

Accession

0001493152-18-005016

Insider Transaction Report

Form 4/AAmended
Period: 2016-06-08
Gormally John J
Chief Executive Officer
Transactions
  • Award

    Common Stock

    2016-06-08$1.99/sh+27,500$54,72530,000 total
Footnotes (1)
  • [F1]On June 8, 2016 Mr. Gormally was issued 27,500 shares of common stock (the "Shares") under the Company's 2013 Incentive Stock and Award Plan, as amended. Pursuant to the Restricted Stock Agreement between Mr. Gormally and the Company governing the issuance of the Shares, 9,167 of the Shares vested on June 8, 2016, 9,167 of the Shares will vest on March 1, 2017, and 9,166 of the Shares will vest on March 1, 2018.

Documents

1 file

Issuer

Akers Biosciences, Inc.

CIK 0001321834

Entity typeother

Related Parties

1
  • filerCIK 0001661118

Filing Metadata

Form type
4/A
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 8:40 PM ET
Size
5.2 KB